Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats.

Benmansour S, Arroyo LD, Frazer A.

Front Aging Neurosci. 2016 Dec 21;8:311. doi: 10.3389/fnagi.2016.00311. eCollection 2016.


The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging.

Brown PJ, Rutherford BR, Yaffe K, Tandler JM, Ray JL, Pott E, Chung S, Roose SP.

Am J Geriatr Psychiatry. 2016 Nov;24(11):1084-1094. doi: 10.1016/j.jagp.2016.06.005. Epub 2016 Jun 23. Review.


Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):588-603. doi: 10.1177/0706743716659276. Epub 2016 Aug 2.


Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Lenze EJ, Mulsant BH, Blumberger DM, Karp JF, Newcomer JW, Anderson SJ, Dew MA, Butters MA, Stack JA, Begley AE, Reynolds CF 3rd.

Lancet. 2015 Dec 12;386(10011):2404-12. doi: 10.1016/S0140-6736(15)00308-6. Epub 2015 Sep 27. Erratum in: Lancet. 2015 Dec 12;386(10011):2394.


Changes in Mood in New Enrollees at a Program of All-Inclusive Care for the Elderly.

Vouri SM, Crist SM, Sutcliffe S, Austin S.

Consult Pharm. 2015 Aug;30(8):463-71. doi: 10.4140/TCP.n.2015.463.


Applications of magnetic resonance imaging for treatment-resistant late-life depression.

Agudelo C, Aizenstein HJ, Karp JF, Reynolds CF 3rd.

Dialogues Clin Neurosci. 2015 Jun;17(2):151-69. Review.


Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.

Lavretsky H, Reinlieb M, St Cyr N, Siddarth P, Ercoli LM, Senturk D.

Am J Psychiatry. 2015 Jun;172(6):561-9. doi: 10.1176/appi.ajp.2014.14070889. Epub 2015 Feb 13.


Levomilnacipran for the treatment of major depressive disorder: a review.

Asnis GM, Henderson MA.

Neuropsychiatr Dis Treat. 2015 Jan 9;11:125-35. doi: 10.2147/NDT.S54710. eCollection 2015. Review.


Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury.

Albrecht JS, Kiptanui Z, Tsang Y, Khokhar B, Smith GS, Zuckerman IH, Simoni-Wastila L.

J Neurotrauma. 2015 Aug 15;32(16):1223-9. doi: 10.1089/neu.2014.3651. Epub 2015 Mar 25.


Depression among older adults with diabetes mellitus.

Park M, Reynolds CF 3rd.

Clin Geriatr Med. 2015 Feb;31(1):117-37, ix. doi: 10.1016/j.cger.2014.08.022. Epub 2014 Nov 15. Review.


Clinical effectiveness of integrating depression care management into medicare home health: the Depression CAREPATH Randomized trial.

Bruce ML, Raue PJ, Reilly CF, Greenberg RL, Meyers BS, Banerjee S, Pickett YR, Sheeran TF, Ghesquiere A, Zukowski DM, Rosas VH, McLaughlin J, Pledger L, Doyle J, Joachim P, Leon AC.

JAMA Intern Med. 2015 Jan;175(1):55-64. doi: 10.1001/jamainternmed.2014.5835.


Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Hsiao JJ, Teng E.

Neurodegener Dis Manag. 2013;3(2):147-155.


Major depressive disorder in older adults: benefits and hazards of prolonged treatment.

Diniz BS, Reynolds CF 3rd.

Drugs Aging. 2014 Sep;31(9):661-9. doi: 10.1007/s40266-014-0196-y. Review.


Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.

Montgomery SA, Gommoll CP, Chen C, Greenberg WM.

CNS Spectr. 2015 Apr;20(2):148-56. doi: 10.1017/S1092852914000273. Epub 2014 Jun 5.


Voluntary wheel running does not affect lipopolysaccharide-induced depressive-like behavior in young adult and aged mice.

Martin SA, Dantzer R, Kelley KW, Woods JA.

Neuroimmunomodulation. 2014;21(1):52-63. doi: 10.1159/000356144. Epub 2013 Nov 20.


A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Bombardier CH, Fann JR, Wilson CS, Heinemann AW, Richards JS, Warren AM, Brooks L, Warms CA, Temkin NR, Tate DG.

J Spinal Cord Med. 2014 May;37(3):247-63. doi: 10.1179/2045772313Y.0000000138. Epub 2013 Nov 26.


Mental health service use among depressed, low-income homebound middle-aged and older adults.

Choi NG, Kunik ME, Wilson N.

J Aging Health. 2013 Jun;25(4):638-55. doi: 10.1177/0898264313484059. Epub 2013 Apr 11.


Dynamic prediction of treatment response in late-life depression.

Joel I, Begley AE, Mulsant BH, Lenze EJ, Mazumdar S, Dew MA, Blumberger D, Butters M, Reynolds CF 3rd; IRL GREY Investigative Team.

Am J Geriatr Psychiatry. 2014 Feb;22(2):167-76. doi: 10.1016/j.jagp.2012.07.002. Epub 2013 Feb 6.


Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response.

Mackin RS, Tosun D, Mueller SG, Lee JY, Insel P, Schuff N, Truran-Sacrey D, Arean P, Nelson JC, Weiner MW.

Am J Geriatr Psychiatry. 2013 Aug;21(8):794-802. doi: 10.1016/j.jagp.2013.01.013. Epub 2013 Feb 6.


Translating geriatric psychiatry research into practice: coping with uncertainty.

Rapoport MJ.

Can Geriatr J. 2012 Jun;15(2):28-30. doi: 10.5770/cgj.15.43. Epub 2012 Jul 3. No abstract available.

Supplemental Content

Support Center